Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02025439 · ClinicalTrials.gov registry record · NA
Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness
A NA study, sponsored by Edward Hines Jr. VA Hospital.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02025439 is a NA study that has completed, run by Edward Hines Jr. VA Hospital. The registered enrollment target is 4 participants.
The verdict
NCT02025439, a NA study, has completed, sponsored by Edward Hines Jr. VA Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) combined with Amantadine relative to rTMS Alone and Amantadine Alone for persons in chronic states of seriously impaired consciousness. The hypothesis is that provision of rTMS+Amantadine will provide a safe yet synergistic effect that induces or accelerates functional recovery.
Interventions
- DEVICE rTMS
- DRUG Amantadine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02025439
The ClinicalTrials.gov registry entry for NCT02025439 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edward Hines Jr. VA Hospital, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which rTMS is the first listed.
NCT02025439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02025439 about?
NCT02025439 is a clinical study titled "Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness". The purpose of this study is to examine the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) combined with Amantadine relative to rTMS Alone and Amantadine Alone for persons in chronic states of seriously impaired consciousness. The hypothesis is that provision of rTMS+Aman...
What is the current status of trial NCT02025439?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2014-02. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02025439?
The interventions under investigation include: rTMS (DEVICE), Amantadine (DRUG).
Who is sponsoring clinical trial NCT02025439?
This trial is sponsored by Edward Hines Jr. VA Hospital, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.